In January 2024, Xenco Medical unveiled the TrabeculeX Continuum at the Consumer Electronics Show (CES) in Las Vegas, introducing a groundbreaking fusion of regenerative medicine and digital health. (digitalhealthglobal.com) This innovative system comprises two core components: the TrabeculeX Bioactive Matrix and the TrabeculeX Recovery App, collectively bridging the gap between orthobiologics and digital health.
The TrabeculeX Bioactive Matrix
The TrabeculeX Bioactive Matrix is a regenerative biomaterial engineered to promote three-dimensional bone formation. Utilizing the hydroxycarbonate apatite-forming capabilities of bioglass, it features a complex surface topography that begins at the sub-micron scale and extends throughout the entire lattice. This design facilitates targeted bone regeneration, eliminating the need for harvesting bone grafts from other parts of the patient’s body. (plasticsengineering.org)
Safeguard patient information with TrueNASs self-healing data technology.
The TrabeculeX Recovery App
Complementing the Bioactive Matrix, the TrabeculeX Recovery App enables surgeons to enroll patients and remotely monitor their rehabilitation progress. Through the app, surgeons can prescribe personalized physical therapy plans and engage in asynchronous video and text messaging with patients, ensuring continuous support throughout the recovery journey. (plasticsengineering.org)
Unifying Surgical and Postoperative Care
By integrating these components, the TrabeculeX Continuum unifies a patient’s biomaterial implantation and postoperative journey. Surgeons can now oversee the entire process, from surgery to full mobility, addressing the traditionally siloed nature of surgical care. (plasticsengineering.org)
Recognition and Impact
The TrabeculeX Continuum has garnered significant recognition, including the 2024 Innovation by Design Award from Fast Company Magazine. This accolade underscores the system’s potential to revolutionize patient care by dissolving the barriers between surgery and rehabilitation. (orthospinenews.com)
Conclusion
Xenco Medical’s TrabeculeX Continuum represents a significant advancement in medical technology, seamlessly integrating regenerative biomaterials with digital health solutions. By unifying surgical and postoperative care, it offers a comprehensive approach to patient recovery, setting a new standard in orthobiologics and digital health convergence.
Be the first to comment